Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1981 3
1982 5
1983 6
1984 6
1985 4
1986 7
1987 9
1988 14
1989 13
1990 13
1991 8
1992 6
1993 7
1994 10
1995 9
1996 13
1997 7
1998 15
1999 14
2000 17
2001 17
2002 18
2003 13
2004 30
2005 24
2006 23
2007 36
2008 48
2009 42
2010 41
2011 58
2012 58
2013 54
2014 56
2015 65
2016 38
2017 31
2018 29
2019 15
2020 6
2021 8
2022 4
2023 6
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

838 results

Results by year

Filters applied: . Clear all
Page 1
When and how to use maraviroc in HIV-infected patients.
Soriano V, Perno CF, Kaiser R, Calvez V, Gatell JM, di Perri G, Pillay D, Rockstroh J, Geretti AM. Soriano V, et al. Among authors: gatell jm. AIDS. 2009 Nov 27;23(18):2377-85. doi: 10.1097/QAD.0b013e328332d32d. AIDS. 2009. PMID: 19834318 Review. No abstract available.
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
González-Cordón A, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Stellbrink HJ, Guaraldi G, Masiá M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Behrens G, Pozniak A, Gatell JM, Martínez E; NEAT 022 Study Group. González-Cordón A, et al. Among authors: gatell jm. J Antimicrob Chemother. 2023 Sep 5;78(9):2361-2365. doi: 10.1093/jac/dkad247. J Antimicrob Chemother. 2023. PMID: 37539492 Free PMC article.
Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir.
Martinez E, Gonzalez-Cordon A, Ferrer E, Domingo P, Negredo E, Gutierrez F, Portilla J, Curran A, Podzamczer D, Murillas J, Bernardino JI, Santos I, Carton JA, Peraire J, Pich J, Perez I, Gatell JM; ATADAR Study Group. Martinez E, et al. Among authors: gatell jm. HIV Med. 2014 Jul;15(6):330-8. doi: 10.1111/hiv.12121. Epub 2014 Jan 12. HIV Med. 2014. PMID: 24417772 Free article. Clinical Trial.
New challenges in therapeutic vaccines against HIV infection.
Leal L, Lucero C, Gatell JM, Gallart T, Plana M, García F. Leal L, et al. Among authors: gatell jm. Expert Rev Vaccines. 2017 Jun;16(6):587-600. doi: 10.1080/14760584.2017.1322513. Epub 2017 May 4. Expert Rev Vaccines. 2017. PMID: 28431490 Review.
48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial.
de Lazzari E, Di Gregorio S, Rojas J, Curran A, Domingo P, Negredo E, Tiraboschi J, Gonzalez-Cordon A, Torres B, Sempere A, Inciarte A, Gatell JM, Blanco JL, Martinez E; DOLAM study group. de Lazzari E, et al. Among authors: gatell jm. J Antimicrob Chemother. 2025 Aug 1;80(8):2226-2233. doi: 10.1093/jac/dkaf192. J Antimicrob Chemother. 2025. PMID: 40556520 Clinical Trial.
[Should we follow the guidelines?].
Gatell JM. Gatell JM. Enferm Infecc Microbiol Clin. 2009 Apr;27(4):197-8. doi: 10.1016/j.eimc.2009.01.002. Epub 2009 Mar 31. Enferm Infecc Microbiol Clin. 2009. PMID: 19339081 Spanish. No abstract available.
[Secondary effects associated with raltegravir].
Gatell JM, Zamora L. Gatell JM, et al. Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 12:34-9. doi: 10.1016/s0213-005x(08)76571-6. Enferm Infecc Microbiol Clin. 2008. PMID: 19572424 Review. Spanish.
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
Waters L, Assoumou L, González-Cordón A, Rusconi S, Domingo P, Gompels M, de Wit S, Raffi F, Stephan C, Masiá M, Rockstroh J, Katlama C, Behrens GMN, Moyle G, Johnson M, Fox J, Stellbrink HJ, Guaraldi G, Florence E, Esser S, Gatell JM, Pozniak A, Martínez E; NEAT 022 Study Group. Waters L, et al. Among authors: gatell jm. Clin Infect Dis. 2023 Mar 4;76(5):861-870. doi: 10.1093/cid/ciac827. Clin Infect Dis. 2023. PMID: 36259527 Free PMC article. Clinical Trial.
Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).
Expert Panel of GESIDA and the National AIDS Plan; Berenguer J, Polo R, Aldeguer JL, Lozano F, Aguirrebengoa K, Arribas JR, Blanco JR, Boix V, Casado JL, Clotet B, Crespo M, Domingo P, Estrada V, García F, Gatell JM, González-García J, Gutiérrez F, Iribarren JA, Knobel H, Llibre JM, Locutura J, López JC, Miró JM, Moreno S, Podzamczer D, Portilla J, Pulido F, Ribera E, Riera M, Rubio R, Santos J, Sanz-Moreno J, Sanz J, Téllez MJ, Tuset M, Rivero A. Expert Panel of GESIDA and the National AIDS Plan, et al. Among authors: gatell jm. Enferm Infecc Microbiol Clin. 2015 Oct;33(8):544-56. doi: 10.1016/j.eimc.2015.03.017. Epub 2015 May 26. Enferm Infecc Microbiol Clin. 2015. PMID: 26021186
An Update on Heart Transplantation in Human Immunodeficiency Virus-Infected Patients.
Agüero F, Castel MA, Cocchi S, Moreno A, Mestres CA, Cervera C, Pérez-Villa F, Tuset M, Cartañà R, Manzardo C, Guaraldi G, Gatell JM, Miró JM. Agüero F, et al. Among authors: gatell jm. Am J Transplant. 2016 Jan;16(1):21-8. doi: 10.1111/ajt.13496. Epub 2015 Nov 2. Am J Transplant. 2016. PMID: 26523614 Free article. Review.
838 results